Global ZikaVirus Testing Market was valued at USD 131.9 million in 2016 and is estimated to grow significantly due to the growing demand for diagnostics from different parts of the world. Zika Virus is a disease by mosquitos that targets pregnant ladies especially the fetus. In 2016, there was a sudden outburst of Zika Virus, which led to a massive demand for point-of-care testing diagnostic tests.
The
diagnostic test is not location specific with no special requirements for
special laboratory setup. The point-of-care test comprises RT-PCR, serology
IgG/IgM Antibody detection, ELISA and with no laboratory organization. These
tests are undertaken in riskier surroundings, which display harsh symptoms of
Zika Virus like fever in pregnancy along with rashes, muscle pain or joint pain
and conjunctivitis. The disease can be transferred form one individual to
another either by sexual contact or from mother to fetus while pregnancy. The
disease prevention planning and funding therapeutic and is expected to boost the
market growth in the coming years with a CAGR of 7.6%.
No
proper vaccination has been found against Zika Virus till date in spite of the
extensive ongoing research; hence to relieve the symptoms care and comfort is
the only way to deal with this situation. Zika Virus detection kit is available
for qualitative tests that are helpful in detecting RNA of Zika Virus from the
body samples like plasma, urine and serum. After detection of Zika Virus is in
the body, antibodies Immunoglobulin M (IgM) are developed against the virus.
The Zika Virus RNA detection test and the positive serum test for
Immunoglobulin M (IgM) are performed to check and ascertain the presence of
Zika Virus in the body.
The
research and development activities have been increased by the leading market
players due to the government initiatives for the emergence of enhanced tests
for detecting Zika Virus. The speedy growing prevalence of Zika Virus testing
infection, increasing awareness regarding early detection and rising efforts by
the manufacturers to introduce Zika Virus detection tests are predicted to
drive the market growth. Moreover, the slow speed of adoption of modern
technologies & lack of awareness in emerging nations and enormous costs of
branded test kits are estimated to bring obstacles in the growth of Zika Virus
Testing Market in the near future. Also, incorrect results from defective
diagnostic techniques can affect the Zika Virus Testing Market.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/zika-virus-testing-market/request-sample
Currently,
the Zika Virus detection is done in view of clinical manifestations. The
serological devices and molecular detection are also important. Since the
segmentation of this virus is difficult, NASBA, LFAs, and LAMP help in
detecting and confirming reason behind fever. These new techniques have
supported in faster and accurate detection of the virus.
The
market is categorized on the basis of test type, end user and geography. On the
basis of test type, the market is divided into serological tests and molecular
diagnostic tests which is also called as nucleic acid amplification tests. The
commonly used test is molecular diagnosis tests. It is (RT-PCR) Reverse
Transcriptase Polymerase Chain Reaction that detects the existence of the Zika
virus in human serum. The serological tests are dependent on the detection of
IgM and IgG antibodies in the human’s serum by ELISA-based tests. On the basis
of end-user, the Zika Virus Testing Market can be divided into diagnostic &
pathological laboratories, contract research organizations, hospitals, and
academic & research institutes.
Geographically,
the market is segmented into Latin America, North America, Asia Pacific, Europe
and Middle East & Africa. North America is expected to dominate the market
largely in the coming years due to the speedy growth of Zika virus in the
region. After North America, Europe is expected to contribute the Zika Virus
Testing Market at a significant pace. The Zika Virus Testing Market in Asia
Pacific is predicted to grow in the coming years owing to the increasing
awareness of Zika Virus and the emerging healthcare industry in the area. The
prominent players in the Zika Virus Testing Industry are ARUP Laboratories,
Luminex Corporation, Hologic, Siemens Healthcare Diagnostics and Roche
Molecular Systems.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/zika-virus-testing-market
Market Segment:
Zika
Virus Testing Test Type Outlook (Revenue, USD Million, 2016 - 2027)
• Nucleic Acid Amplification Testing (NAAT)
• Serological Testing
Zika
Virus Testing Regional Outlook (Revenue, USD Million, 2016 - 2027)
• U.S. States & Territories
• U.S. States
• U.S. Territories
• Europe
• Continental Europe
• Caribbean
• Asia Pacific
• Singapore
• Vietnam
• Indonesia
• Latin America
• Brazil
• Colombia
• Africa
Read more insights on @
https://latestmarkettrends.news.blog
Get in touch
At Million Insights, we work with the aim to reach the highest levels
of customer satisfaction. Our representatives strive to understand diverse
client requirements and cater to the same with the most innovative and
functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
I am really very much satisfied after reading this post. All updated information on the Ultra Filtration Plant is mentioned in this post and hence, one can easily understand all details.
ReplyDelete